Pharmaceuticals
Company Overview of Invivis Pharmaceuticals Inc.
Executive Profile
Alexander M.M. Eggermont M.D., Ph.D.Member of Scientific Committee and Member of The Board of Directors, Invivis Pharmaceuticals Inc. |
| Age | Total Calculated Compensation | This person is connected to 2 Board Members in 2 different organizations across 3 different industries. See Board Relationships |
| -- | -- |
Background
Dr. Alexander M. M. Eggermont, M.D., Ph.D serves as a Client Consultant of NovaRx Corporationc. Mr. Eggermontis a Full Professor of Surgical Oncology and serves as Head of the Department of Surgical Oncology of the Erasmus University Medical Center - Daniel den Hoed Cancer Center in Rotterdam, The Netherlands. Mr. Eggermont serves as the Chairman of Experimental Surgical Oncology endowed by the Dutch Cancer Society and the "Joseph Maisin Chair" for Surgical Oncology ...
Corporate Headquarters547 Meadow RoadBridgewater, New Jersey 08807 United States Phone: 908-818-9393 Fax: 888-591-1834 Board Members MembershipsMember of Scientific Committee and Member of The Board of Directors
EducationPhD 1987 Erasmus University
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Ohio | Boehringer IngelheimPosted: May 05
- Fort Collins, CO | AstraZenecaPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
To contact Invivis Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








